OK Biotech Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for OK Biotech.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 22.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings
Aug 20
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend
Apr 26Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)
Apr 04OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet
Mar 17Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?
Mar 01Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?
Feb 15A Look At OK Biotech's (TPE:4155) Share Price Returns
Jan 31We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide
Jan 17
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend
Jan 03Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)
Dec 21Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly
Dec 08Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?
Nov 23In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as OK Biotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 1,525 | 23 | -309 | 73 | N/A |
| 6/30/2024 | 1,343 | 48 | -32 | 179 | N/A |
| 3/31/2024 | 1,223 | 21 | -152 | 19 | N/A |
| 12/31/2023 | 1,192 | 3 | -434 | 3 | N/A |
| 9/30/2023 | 1,238 | 29 | -227 | 144 | N/A |
| 6/30/2023 | 1,271 | 74 | -390 | 196 | N/A |
| 3/31/2023 | 1,387 | 113 | -359 | 236 | N/A |
| 12/31/2022 | 1,484 | 143 | -54 | 241 | N/A |
| 9/30/2022 | 1,519 | 147 | -72 | 210 | N/A |
| 6/30/2022 | 1,520 | 116 | 45 | 129 | N/A |
| 3/31/2022 | 1,385 | 62 | -14 | 63 | N/A |
| 12/31/2021 | 1,263 | 43 | -65 | 22 | N/A |
| 9/30/2021 | 1,358 | 81 | -124 | 27 | N/A |
| 6/30/2021 | 1,391 | 92 | -44 | 43 | N/A |
| 3/31/2021 | 1,410 | 113 | 8 | 108 | N/A |
| 12/31/2020 | 1,484 | 130 | 68 | 148 | N/A |
| 9/30/2020 | 1,407 | 127 | -33 | 45 | N/A |
| 6/30/2020 | 1,356 | 139 | -11 | 112 | N/A |
| 3/31/2020 | 1,330 | 143 | -117 | -7 | N/A |
| 12/31/2019 | 1,241 | 126 | -32 | 82 | N/A |
| 9/30/2019 | 1,169 | 133 | 36 | 87 | N/A |
| 6/30/2019 | 1,145 | 144 | -48 | 0 | N/A |
| 3/31/2019 | 1,107 | 148 | 65 | 90 | N/A |
| 12/31/2018 | 1,120 | 161 | 77 | 105 | N/A |
| 9/30/2018 | 1,075 | 148 | 57 | 107 | N/A |
| 6/30/2018 | 1,157 | 139 | N/A | 148 | N/A |
| 3/31/2018 | 1,239 | 143 | N/A | 153 | N/A |
| 12/31/2017 | 1,233 | 127 | N/A | 98 | N/A |
| 9/30/2017 | 1,281 | 116 | N/A | 123 | N/A |
| 6/30/2017 | 1,182 | 80 | N/A | 155 | N/A |
| 3/31/2017 | 1,092 | 74 | N/A | 149 | N/A |
| 12/31/2016 | 1,040 | 85 | N/A | 261 | N/A |
| 9/30/2016 | 964 | 97 | N/A | 253 | N/A |
| 6/30/2016 | 942 | 123 | N/A | 272 | N/A |
| 3/31/2016 | 894 | 122 | N/A | 338 | N/A |
| 12/31/2015 | 857 | 111 | N/A | 289 | N/A |
| 9/30/2015 | 758 | 97 | N/A | N/A | N/A |
| 6/30/2015 | 660 | 83 | N/A | 237 | N/A |
| 3/31/2015 | 647 | 77 | N/A | 102 | N/A |
| 12/31/2014 | 634 | 71 | N/A | -34 | N/A |
| 9/30/2014 | 784 | 84 | N/A | N/A | N/A |
| 6/30/2014 | 934 | 96 | N/A | -79 | N/A |
| 3/31/2014 | 1,004 | 117 | N/A | 4 | N/A |
| 12/31/2013 | 1,074 | 138 | N/A | 87 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4155's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if 4155's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4155's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4155's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 4155's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4155's Return on Equity is forecast to be high in 3 years time